ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
Article in Targeted Oncology (April 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Article in Targeted Oncology (April 2024)
Article in Cancers (January 2024)
Book chapter (January 2024)